Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0WDSGS
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
5T4-FC-Mc-Lys-MMETA
|
|||||
| Synonyms |
5T4 FC mc Lys MMETA
Click to Show/Hide
|
|||||
| Organization |
AstraZeneca Pharmaceuticals LP
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 4 Indication(s)
Breast cancer [ICD11:2C60-2C65]
Clinical candidate
Cervical cancer [ICD11:2C77]
Clinical candidate
Gastric cancer [ICD11:2B72]
Clinical candidate
Lung cancer [ICD11:2C25]
Clinical candidate
|
|||||
| Structure |
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Trophoblast glycoprotein (TPBG)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
| Combination Type |
AZ1508
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.